Crossmark

Glomerular filtration rate change during chronic hepatitis C treatment with Sofosbuvir/Ledipasvir in HCV/HIV Coinfected patients treated with Tenofovir and a boosted protease inhibitor: an observational prospective study

Crossref DOI link: https://doi.org/10.1186/s12879-018-3278-3

Published Online: 2018-08-03

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Soeiro, Cristina Aurora São Pedro

Gonçalves, Celina Andreia Melo

Marques, Marta Sofia Correia

Méndez, Maria Josefina Vazquez

Tavares, Ana Paula Ribeiro Almeida

Horta, Ana Maria Lacerda Morgado Fernandes

Sarmento-Castro, Rui Manuel do Rosário
License Information

Text and Data Mining valid from 2018-08-03
More Information

Article History

Received: 28 November 2017

Accepted: 27 July 2018

First Online: 3 August 2018

Ethics approval and consent to participate

: This study was approved by the Ethical Commission of Centro Hospitalar do Porto and by the Portuguese National Data Protection Commission. Written informed consent was obtained for all patients.

: All authors agreed with the final manuscript and consented publication. Participants consented publication.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below